SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-040626
Filing Date
2024-03-28
Accepted
2024-03-28 17:23:18
Documents
14
Period of Report
2024-03-27
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2410125d1_8k.htm   iXBRL 8-K 27800
  Complete submission text file 0001104659-24-040626.txt   246190

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cycc-20240327.xsd EX-101.SCH 3260
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cycc-20240327_def.xml EX-101.DEF 26928
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycc-20240327_lab.xml EX-101.LAB 36551
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycc-20240327_pre.xml EX-101.PRE 25552
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2410125d1_8k_htm.xml XML 5355
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 24800529
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)